| JYSB2100045 | 注射用重组人凝血因子Ⅸ | Recombinant Coagulation Factor Ⅸ | Lyophilized | Biological Products | Supplementary Application | 2021-02-19 | | | In Review | 2021-02-18 | view |
| JYSB1900233 | 注射用重组人凝血因子Ⅸ | Recombinant Coagulation Factor Ⅸ | Lyophilized | Biological Products | Supplementary Application | 2019-08-30 | | | Filed | 2019-09-11 | view |
| JYSZ1700002 | 注射用重组人凝血因子Ⅸ | Recombinant Coagulation Factor Ⅸ | Lyophilized | Biological Products | License Renew | 2017-02-27 | 惠氏制药有限公司 | Wyeth Pharmaceutical Co Ltd | Certificate Issued | 2018-07-25 | view |
| JYSZ2200033 | 注射用重组人凝血因子Ⅸ | Recombinant Coagulation Factor Ⅸ | Lyophilized | Biological Products | License Renew | 2022-07-21 | | | | | view |
| JYSB1700119 | 注射用重组人凝血因子Ⅸ | Recombinant Coagulation Factor Ⅸ | Lyophilized | Biological Products | Supplementary Application | 2017-06-26 | 惠氏制药有限公司 | Wyeth Pharmaceutical Co Ltd | Certificate Issued | 2018-07-25 | view |
| JYSB1900076 | 注射用重组人凝血因子Ⅸ | Recombinant Coagulation Factor Ⅸ | Lyophilized | Biological Products | Supplementary Application | 2019-04-26 | | | Certificate Issued | 2019-10-30 | view |
| JYSB1900271 | 注射用重组人凝血因子Ⅸ | Recombinant Coagulation Factor Ⅸ | Lyophilized | Biological Products | Supplementary Application | 2019-09-21 | | | Certificate Issued | 2019-10-28 | view |
| JYSB1700034 | 注射用重组人凝血因子Ⅸ | Recombinant Coagulation Factor Ⅸ | Lyophilized | Biological Products | Supplementary Application | 2017-03-20 | 惠氏制药有限公司 | Wyeth Pharmaceutical Co Ltd | Certificate Issued | 2018-07-25 | view |
| JYSZ2200035 | 注射用重组人凝血因子Ⅸ | Recombinant Coagulation Factor Ⅸ | Lyophilized | Biological Products | License Renew | 2022-07-21 | | | | | view |
| JYSB2000371 | 注射用重组人凝血因子Ⅸ | Recombinant Coagulation Factor Ⅸ | Lyophilized | Biological Products | Supplementary Application | 2020-08-10 | | | Filed | 2020-08-19 | view |
| JYSB1800271 | 注射用重组人凝血因子Ⅸ | Recombinant Coagulation Factor Ⅸ | Lyophilized | Biological Products | Supplementary Application | 2018-12-03 | | | Certificate Issued | 2019-12-20 | view |
| JYSB1900274 | 注射用重组人凝血因子Ⅸ | Recombinant Coagulation Factor Ⅸ | Lyophilized | Biological Products | Supplementary Application | 2019-09-21 | | | Certificate Issued | 2019-10-28 | view |
| JYSB1700033 | 注射用重组人凝血因子Ⅸ | Recombinant Coagulation Factor Ⅸ | Lyophilized | Biological Products | Supplementary Application | 2017-03-20 | 惠氏制药有限公司 | Wyeth Pharmaceutical Co Ltd | Certificate Issued | 2018-07-25 | view |
| JYSB2000374 | 注射用重组人凝血因子Ⅸ | Recombinant Coagulation Factor Ⅸ | Lyophilized | Biological Products | Supplementary Application | 2020-08-10 | | | Filed | 2020-08-19 | view |
| JYSB1800270 | 注射用重组人凝血因子Ⅸ | Recombinant Coagulation Factor Ⅸ | Lyophilized | Biological Products | Supplementary Application | 2018-12-03 | | | Certificate Issued | 2019-12-20 | view |
| JYSB2100048 | 注射用重组人凝血因子Ⅸ | Recombinant Coagulation Factor Ⅸ | Lyophilized | Biological Products | Supplementary Application | 2021-02-19 | | | In Review | 2021-02-18 | view |
| JYSB1900232 | 注射用重组人凝血因子Ⅸ | Recombinant Coagulation Factor Ⅸ | Lyophilized | Biological Products | Supplementary Application | 2019-08-30 | | | Filed | 2019-09-11 | view |
| JYSZ1700001 | 注射用重组人凝血因子Ⅸ | Recombinant Coagulation Factor Ⅸ | Lyophilized | Biological Products | License Renew | 2017-02-27 | 惠氏制药有限公司 | Wyeth Pharmaceutical Co Ltd | Certificate Issued | 2018-07-25 | view |
| JYSB1700118 | 注射用重组人凝血因子Ⅸ | Recombinant Coagulation Factor Ⅸ | Lyophilized | Biological Products | Supplementary Application | 2017-06-26 | 惠氏制药有限公司 | Wyeth Pharmaceutical Co Ltd | Certificate Issued | 2018-07-25 | view |
| JYSB1900075 | 注射用重组人凝血因子Ⅸ | Recombinant Coagulation Factor Ⅸ | Lyophilized | Biological Products | Supplementary Application | 2019-04-26 | | | Certificate Issued | 2019-10-30 | view |
